InvestorsHub Logo
Followers 0
Posts 1200
Boards Moderated 0
Alias Born 05/05/2017

Re: None

Wednesday, 01/01/2020 11:10:33 AM

Wednesday, January 01, 2020 11:10:33 AM

Post# of 44784
So much for First things FIRST....

“....the first being a safe, effective, and efficient alternative to bone marrow transplantation,” according to Pluristem chairman and CEO, Zami Aberman."

“We intend to develop this technology platform into a functional stem cell production system for the treatment of a variety of indications; the first being a safe, effective, and efficient alternative to bone marrow transplantation,” according to Pluristem chairman and CEO, Zami Aberman.